SUN PHARMACEUTICAL INDUSTRIES INC Recalls Fluocinonide
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
SUN PHARMACEUTICAL INDUSTRIES INC Recalls Fluocinonide
SUN PHARMACEUTICAL INDUSTRIES INC · Class II — Moderate Risk

Product Description
Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceuticals Inc., Brampton, Ontario, Canada L6T 1C1, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, NDC 51672-1386-3.
Reason for Recall
Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Nationwide in the USA.
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
SUN PHARMACEUTICAL INDUSTRIES INC has recalled a pharmaceutical product that the FDA classified as Class II affecting 2,640 60g tubes. The recall was initiated on March 25, 2026. Failed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing. It was distributed nationwide. Class II recalls involve products that might cause a temporary health problem or pose only a slight threat of a serious nature. Consumers should discontinue use and contact the firm.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.